ATE278778T1 - Stabilisierende peptide, und polypeptide und antikörper die diese beinhalten - Google Patents

Stabilisierende peptide, und polypeptide und antikörper die diese beinhalten

Info

Publication number
ATE278778T1
ATE278778T1 AT00204725T AT00204725T ATE278778T1 AT E278778 T1 ATE278778 T1 AT E278778T1 AT 00204725 T AT00204725 T AT 00204725T AT 00204725 T AT00204725 T AT 00204725T AT E278778 T1 ATE278778 T1 AT E278778T1
Authority
AT
Austria
Prior art keywords
polypeptides
antibodies
contain
peptides
stabilizing peptides
Prior art date
Application number
AT00204725T
Other languages
English (en)
Inventor
Eugenio Benvenuto
Rosella Franconi
Angiola Desiderio
Paraskevi Tavladoraki
Original Assignee
Enea Ente Nuove Tec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enea Ente Nuove Tec filed Critical Enea Ente Nuove Tec
Application granted granted Critical
Publication of ATE278778T1 publication Critical patent/ATE278778T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/13—Immunoglobulins specific features characterized by their source of isolation or production isolated from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00204725T 1999-12-30 2000-12-21 Stabilisierende peptide, und polypeptide und antikörper die diese beinhalten ATE278778T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000803A IT1307309B1 (it) 1999-12-30 1999-12-30 Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.

Publications (1)

Publication Number Publication Date
ATE278778T1 true ATE278778T1 (de) 2004-10-15

Family

ID=11407125

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00204725T ATE278778T1 (de) 1999-12-30 2000-12-21 Stabilisierende peptide, und polypeptide und antikörper die diese beinhalten

Country Status (10)

Country Link
US (1) US20030157090A1 (de)
EP (1) EP1120464B1 (de)
JP (1) JP2003518941A (de)
AT (1) ATE278778T1 (de)
AU (1) AU2397701A (de)
CA (1) CA2395041A1 (de)
DE (1) DE60014575T2 (de)
IL (1) IL150067A0 (de)
IT (1) IT1307309B1 (de)
WO (1) WO2001049713A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7481999B2 (en) 1998-05-05 2009-01-27 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin-mediated function
US20050037420A1 (en) * 2001-09-14 2005-02-17 Mei-Yun Zhang Immunoglobulin having particular framework scaffold and methods of making and using
US20050214857A1 (en) * 2001-12-11 2005-09-29 Algonomics N.V. Method for displaying loops from immunoglobulin domains in different contexts
AU2002359913A1 (en) * 2001-12-20 2003-07-09 Agricultural Research Council Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes
US7047448B2 (en) * 2002-11-21 2006-05-16 Bitfone Corporation Software self-repair toolkit for electronic devices
US8663650B2 (en) 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
EP1500662A3 (de) * 2003-05-19 2005-09-21 Cornell Research Foundation, Inc. Stabilisierende Peptide und Ihre Verwendung zur Herstellung von stabilisierten HIV-Inhibitoren
DOP2006000277A (es) 2005-12-12 2007-08-31 Bayer Pharmaceuticals Corp Anticuerpos anti mn y métodos para su utilización
US20100298225A1 (en) * 2007-07-15 2010-11-25 Bjarne Due Larsen Peptide gap junction modulators
WO2010080910A1 (en) * 2009-01-08 2010-07-15 Bio-Rad Laboratories, Inc. Methods and compositions for improving efficiency of nucleic acids amplification reactions
US8945569B2 (en) 2009-11-19 2015-02-03 Oncomed Pharmaceuticals, Inc. Jagged-binding agents and uses thereof
KR101580713B1 (ko) 2010-02-24 2015-12-29 이뮤노젠 아이엔씨 엽산염 수용체 1 항체와 면역접합체 및 이들의 용도
UA125636C2 (uk) 2011-04-01 2022-05-11 Іммуноджен, Інк. Способи ідентифікації раку, який може реагувати на анти-folr1 антитіло або анти-folr1 імунокон'югат
ES2682254T3 (es) 2011-08-18 2018-09-19 Affinity Biosciences Pty Ltd Polipéptidos solubles
KR20200079565A (ko) 2012-08-31 2020-07-03 이뮤노젠 아이엔씨 엽산 수용체 1의 검출을 위한 진단성 검정 및 키트
WO2015031815A2 (en) 2013-08-30 2015-03-05 Immunogen, Inc. Antibodies and assays for detection of folate receptor 1
IL257531B2 (en) 2015-09-17 2023-04-01 Immunogen Inc Medicinal compositions containing anti-folr1 immunoconjugates
US20220098320A1 (en) * 2019-02-01 2022-03-31 Memorial Sloan Kettering Cancer Center Senolytic car-t cells targeting upar, a cell surface and secreted senescence biomarker

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins

Also Published As

Publication number Publication date
IL150067A0 (en) 2002-12-01
WO2001049713A3 (en) 2002-01-03
JP2003518941A (ja) 2003-06-17
CA2395041A1 (en) 2001-07-12
ITRM990803A1 (it) 2001-06-30
DE60014575T2 (de) 2005-10-13
DE60014575D1 (de) 2004-11-11
EP1120464B1 (de) 2004-10-06
WO2001049713A2 (en) 2001-07-12
AU2397701A (en) 2001-07-16
US20030157090A1 (en) 2003-08-21
IT1307309B1 (it) 2001-10-30
EP1120464A2 (de) 2001-08-01
ITRM990803A0 (it) 1999-12-30
EP1120464A3 (de) 2001-10-24

Similar Documents

Publication Publication Date Title
ATE278778T1 (de) Stabilisierende peptide, und polypeptide und antikörper die diese beinhalten
NO20011759D0 (no) Flt4 (VEGFR-3) som målmateriale for tumor-avbildning og anti- tumor-terapi
DE69739219D1 (de) Peptide und zusammensetzungen, die an den thrombopoietin-rezeptor binden
DE68926303T2 (de) Peptide und antikörper, die die integrin-ligandbindung inhibieren
EP0832973A3 (de) GTP-bindende Proteine
SG161738A1 (en) B-amyloid peptide-binding proteins and polynucleotides encoding the same
WO2000005367A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
ATE366812T1 (de) Neue methode zur erkennung eines stoffes, der die interaktion zwischen einem tnf-liganden und seinem rezeptor auf b-zellen moduliert
AU2002227498A1 (en) Tumor antigen
DE69928658T2 (de) Basb029 polynucleotide und polypeptide aus neisseria meningitis
ATE464383T1 (de) Tumor antigen
UA72875C2 (uk) БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ
DE69704269D1 (de) Dendritische, lysinhaltige Polypeptide zur gezielten Arzneimittelabreichung
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
DK0923644T3 (da) G-koblet receptor, der udviser selektiv selektivitet for ATP
EP1140131A4 (de) Peptide und peptidanaloga, abgeleitet vom hfe protein, und deren verwendung in der behandlung von erkrankungen, welche durch eisenüberschuss herrühren
WO2001053453A3 (en) Novel bone marrow nucleic acids and polypeptides
DE69233673D1 (de) Protein S polypeptide und deren Verwendungen
ATE397069T1 (de) Basb205 polypeptide und dafür kodierende polynukleotide
IL139951A0 (en) Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses
ATE399205T1 (de) Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen
IL142664A0 (en) Prv-1 gene, processes for detecting the prv-1 polypeptide and pharmaceutical compositions containing the same
HU0100947D0 (en) Screening system based on expression of abcg2 half transporter protein in an expression system free of other abc-transporters, abcg2 homodimers
DE808846T1 (de) Peptide, die mit Antikörpern reagieren, die den Fortschritt der HIV-Erkrankung markieren
EP0906957A3 (de) Lgt Polypeptid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties